The European Medicines Agency (EMA) has approved Bavarian Nordic’s mpox vaccine for adolescents. This is a major step towards expanding vaccine access for young people, particularly in Africa. The decision comes at a time of growing health concerns and rising mpox cases globally. Bavarian Nordic sought this approval through a type II variation. This process …